Web MD, August 31, 2011. After two days of testimony on what the FDA should do about troubled long-term safety studies of silicone-gel breast implants, agency officials said the studies would continue. Public health research director of the National Research Center for Women & Families, Dana Casciotti, said the 27 page questionaires that are currently being used in the studies are too long and ineffective. In order for the studies to be successful, the questionaires need to be shortened.
Read More »News That Quotes Us & Our Work
We are often quoted in major newspapers and magazines, and on well-respected TV shows, radio programs, and websites where we share our opinion on issues that matter to you and your health. Stay up to date on health news and our take on it by reading the articles in this section.
FDA Affirms Safety of Breast Implants
The New York Times, August 31, 2011. Dr. Diana Zuckerman, president of National Research Center for Women & Families, told an FDA advisory panel that Allergan and Mentor did a poor job studying patients that got silicone implants.
Read More »Experts Say Medical Device Review System Flawed
The Miami Herald, July 29, 2011. NRC President Diana Zuckerman expresses concern over the vast majority of medical devices being cleared through the 510(k) process—a process which has been described as “flawed” by Institute of Medicine panelists in a new report.
Read More »FDA Backs Quicker Reviews for Hip Implants in Reply to Panel’s Report
Bloomberg, July 29, 2011. In an article about the IOM medical device report and the FDA, president of the National Research Center for Women & Families Diana Zuckerman tells Bloomberg: devices that are implanted and “life-sustaining and life- saving should be held to a higher standard.”
Read More »Warning About Pelvic Mesh
WCAX, July 15, 2011. NRC President Diana Zuckerman tells WCAX that pelvic mesh devices have “been used despite no clinical trials, no testing on humans to see if they’re actually safe and effective.
Read More »